(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 18.47% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 11.22%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.4%.
Albemarle's revenue in 2023 is $5,593,330,000.On average, 7 Wall Street analysts forecast ALB's revenue for 2023 to be $1,024,272,735,582, with the lowest ALB revenue forecast at $757,804,136,670, and the highest ALB revenue forecast at $1,376,896,787,882. On average, 6 Wall Street analysts forecast ALB's revenue for 2024 to be $954,537,769,259, with the lowest ALB revenue forecast at $665,078,637,441, and the highest ALB revenue forecast at $1,105,570,916,978.
In 2025, ALB is forecast to generate $1,215,852,699,610 in revenue, with the lowest revenue forecast at $1,206,205,167,024 and the highest revenue forecast at $1,225,500,232,196.